Ads
related to: novartis stock quote- Chipmaker Set to Soar Now
Best 2024 Semiconductor Stock?
One Chipmaker Worth Buying Now
- Top EV Stocks to Buy Now
5 EV Picks Better than Tesla
5 Stocks with Big Profit Potential
- Free: Invest Like Buffett
5 "Buffett stocks" to buy right now
New report names 5 wealth-builders
- 3 Hottest Software Stocks
Top plays from a surging industry.
Free report names must-buy stocks.
- 2024's Gold Rush is Here
Gold Prices Could Reach New Highs
See This Year's Top Gold Plays Free
- Top Hydrogen Stock Plays
5 Hydrogen stocks to buy right now
New report names 5 wealth-builders
- Chipmaker Set to Soar Now
Search results
Novartis (NVS) Spins off Sandoz, Reiterates Annual Outlook
Zacks via Yahoo Finance· 8 months agoNovartis NVS completed the spin-off of its generic and biosimilar unit, Sandoz, following which...
Novartis (NVS) Q2 Earnings & Revenues Top, Guidance Raised
Zacks via Yahoo Finance· 10 months agoSwiss pharma giant Novartis AG NVS reported strong second-quarter 2023 results and shares are...
Novartis (NVS) Tops Q3 Earnings, Ups Operating Income View
Zacks via Yahoo Finance· 7 months agoSwiss pharma giant Novartis AG NVS reported strong sales from key drugs in third-quarter 2023 and...
Novartis (VTX:NOVN) shareholders have earned a 9.9% CAGR over the last five years
Simply Wall St. via Yahoo Finance· 11 months agoWhen we invest, we're generally looking for stocks that outperform the market average. Buying...
Novartis (NVS) to Report Q1 Earnings: What to Expect?
Zacks via Yahoo Finance· 1 month agoNovartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2024 results on Apr 23....
Why Novartis (NVS) Might Surprise This Earnings Season
Zacks via Yahoo Finance· 10 months agoInvestors are always looking for stocks that are poised to beat at earnings season and Novartis AG...
Novartis (NVS) Q2 Earnings Beat, Revenues Miss Estimates
Zacks via Yahoo Finance· 2 years agoNovartis AG NVS reported mixed second-quarter 2022 results. The Sandoz business continues to recover...
Novartis (NVS) to Report Q2 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 10 months agoWhen Novartis (NVS) reports second-quarter 2023 results, investor focus is likely to be on updates...
Novartis (NVS) Presents Positive Data on Rare Kidney Disease Drug
Zacks via Yahoo Finance· 1 month agoNovartis (NVS) announces encouraging data on Fabhalta from a phase III study for the treatment for...
The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Merck, Novartis and AstraZeneca
Zacks via Yahoo Finance· 9 months agoFor Immediate Release Chicago, IL – August 29, 2023 – Zacks.com announces the list of stocks...
